Published on: 18 October 2013
International Regulatory Workshop Biotherapeutic Meidicines
Regulatory Challenges and current practices.
Approaches for harmonization.
Day 2. Session 1
Immunological safety, pharmacovigiliance and risk minimization programs for the biological products.
